secwatch.observer — SEC 8-K summary
======================================

Issuer:     BriaCell Therapeutics Corp. (BCTX)
CIK:        0001610820
Form:       8-K
Filed at:   2025-01-03T23:59:59+00:00
Accession:  0001493152-25-000282
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BriaCell announces 1-for-15 share consolidation to maintain Nasdaq listing
--------------------------------------------------------------------------

- Consolidation ratio: 1 post-consolidation share for every 15 pre-consolidation shares.
- Effective date expected January 24, 2025; trading on TSX and Nasdaq from Jan 29, 2025.
- No fractional shares issued; fractions cancelled for no consideration.
- Convertible securities exercise prices and share counts proportionally adjusted.
- Action needed to comply with Nasdaq Capital Market listing requirements.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1610820/000149315225000282/0001493152-25-000282-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1610820/000149315225000282/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-000282

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer